VERAXA BIOTECH AG
Last · —$1.11-0.09 (-7.50%)live · yahoo · 1h ago
Market cap$156.96M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
Loading chart…
OpenFilings analyst
Our analyst
From latest 20-F · 2026-06-16
- Net Margin Sharply Negative
Red flags
- Net Margin Sharply Negative — Net margin -284359.2%
Press & signals
- GlobeNewswire
VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy
- GlobeNewswire
VERAXA Biotech Appoints Raju Willener as Chief Financial Officer
- GlobeNewswire
VERAXA Biotech and Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate (AOC) Alliance
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags